Pure Global
NCT05503680

The Effect of Yoga for Stress Among HIV Patients in Indonesia

The Effect of a Yoga Intervention for Reducing Stress Among People Living With HIV in Indonesia: A Randomized Controlled Trial
National Taipei University of Nursing and Health Sciences·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
Yoga
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
National Taipei University of Nursing and Health Sciences
Location
Makassar, Indonesia
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2022
End date
Nov 30, 2022
Enrollment
66 participants
Primary outcome

Perceived stress scale (this study will measure the the phenomenon of stress among PLWH using the Perceived Stress Scale developed by Dr. Sheldon Cohen in 1983).

Summary

This study is aimed to evaluate the effects of yoga intervention versus usual care (control
 group) for reducing stress among people living with HIV in Indonesia.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05503680
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05503680 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taipei University of Nursing and Health Sciences and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 66 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.